Timothy A Springer - Insider Trading Tracker

Cartesian Therapeutics, Inc.

US ˙ NasdaqGM

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Timothy A Springer. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Timothy A Springer telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:RNAC / Cartesian Therapeutics, Inc.	Director, 10% Owner	656,513
	Director, 10% Owner	1,503,358
US:MORF / Morphic Holding, Inc.	Director, 10% Owner	0
US:SRRK / Scholar Rock Holding Corporation	10% Owner	2,376,567

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Timothy A Springer. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam RNAC / Cartesian Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam RNAC / Cartesian Therapeutics, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2025-04-11	RNAC	SPRINGER TIMOTHY A	6,412	10.7726	6,412	10.7726	69,074	89	13.7700	19,220	27.83
2025-04-11	RNAC	SPRINGER TIMOTHY A	36,338	10.7726	36,338	10.7726	391,455
2025-04-10	RNAC	SPRINGER TIMOTHY A	7,966	10.4345	7,966	10.4345	83,121
2025-04-10	RNAC	SPRINGER TIMOTHY A	609	10.9231	609	10.9231	6,652
2025-04-10	RNAC	SPRINGER TIMOTHY A	45,144	10.4345	45,144	10.4345	471,055
2025-04-10	RNAC	SPRINGER TIMOTHY A	3,451	10.9231	3,451	10.9231	37,696
2025-04-09	RNAC	SPRINGER TIMOTHY A	7,342	9.4264	7,342	9.4264	69,209
2025-04-09	RNAC	SPRINGER TIMOTHY A	31	9.9509	31	9.9509	308
2025-04-09	RNAC	SPRINGER TIMOTHY A	41,604	9.4264	41,604	9.4264	392,176
2025-04-09	RNAC	SPRINGER TIMOTHY A	178	9.9509	178	9.9509	1,771
2025-03-20	RNAC	SPRINGER TIMOTHY A	54,889	15.5877	54,889	15.5877	855,593
2025-03-19	RNAC	SPRINGER TIMOTHY A	20,234	14.9729	20,234	14.9729	302,962
2025-03-18	RNAC	SPRINGER TIMOTHY A	14,740	14.4233	14,740	14.4233	212,599
2025-01-14	RNAC	SPRINGER TIMOTHY A	4,022	18.0000	4,022	18.0000	72,396
2025-01-13	RNAC	SPRINGER TIMOTHY A	7,962	16.8576	7,962	16.8576	134,220
2025-01-13	RNAC	SPRINGER TIMOTHY A	8,983	17.7822	8,983	17.7822	159,738
2024-12-23	RNAC	SPRINGER TIMOTHY A	5,181	18.9996	5,181	18.9996	98,437
2024-12-20	RNAC	SPRINGER TIMOTHY A	21,800	18.9435	21,800	18.9435	412,968
2024-12-19	RNAC	SPRINGER TIMOTHY A	11,303	17.3858	11,303	17.3858	196,512
2024-12-19	RNAC	SPRINGER TIMOTHY A	10,529	18.3496	10,529	18.3496	193,203
2024-12-19	RNAC	SPRINGER TIMOTHY A	3,376	18.9280	3,376	18.9280	63,901
2024-11-18	RNAC	SPRINGER TIMOTHY A	38,114	17.9579	38,114	17.9579	684,447
2024-11-18	RNAC	SPRINGER TIMOTHY A	20,181	18.4201	20,181	18.4201	371,736
2024-11-15	RNAC	SPRINGER TIMOTHY A	277,246	17.0938	277,246	17.0938	4,739,188
2024-11-14	RNAC	SPRINGER TIMOTHY A	74,157	16.1916	74,157	16.1916	1,200,720
2024-11-14	RNAC	SPRINGER TIMOTHY A	22,242	16.9695	22,242	16.9695	377,436
2024-10-04	RNAC	SPRINGER TIMOTHY A	9,892	21.3501	9,892	21.3501	211,195
2024-10-04	RNAC	SPRINGER TIMOTHY A	48,880	22.3542	48,880	22.3542	1,092,673
2024-10-04	RNAC	SPRINGER TIMOTHY A	16,650	23.5659	16,650	23.5659	392,372
2024-10-04	RNAC	SPRINGER TIMOTHY A	4,879	23.9330	4,879	23.9330	116,769
2024-10-03	RNAC	SPRINGER TIMOTHY A	29,847	18.2456	29,847	18.2456	544,576
2024-10-03	RNAC	SPRINGER TIMOTHY A	10,249	19.0125	10,249	19.0125	194,859
2024-10-03	RNAC	SPRINGER TIMOTHY A	50,489	20.1802	50,489	20.1802	1,018,878
2024-10-03	RNAC	SPRINGER TIMOTHY A	21,278	21.1749	21,278	21.1749	450,560
2024-10-03	RNAC	SPRINGER TIMOTHY A	8,043	21.8625	8,043	21.8625	175,840
2024-10-02	RNAC	SPRINGER TIMOTHY A	5,514	17.3779	5,514	17.3779	95,822
2024-08-12	RNAC	SPRINGER TIMOTHY A	8,016	12.7205	8,016	12.7205	101,968
2024-03-18	RNAC	SPRINGER TIMOTHY A	19,044	0.5985	635	17.9550	11,398
2024-03-18	RNAC	SPRINGER TIMOTHY A	800	0.6100	27	18.3000	488
2024-03-15	RNAC	SPRINGER TIMOTHY A	537,500	0.5852	17,917	17.5560	314,545
2024-03-15	RNAC	SPRINGER TIMOTHY A	1,200	0.5600	40	16.8000	672
2024-03-14	RNAC	SPRINGER TIMOTHY A	648,372	0.5424	21,612	16.2720	351,677
2024-03-14	RNAC	SPRINGER TIMOTHY A	2,000	0.5305	67	15.9150	1,061
2024-03-13	RNAC	SPRINGER TIMOTHY A	3,200	0.5837	107	17.5110	1,868
2024-03-12	RNAC	SPRINGER TIMOTHY A	1,200	0.6122	40	18.3660	735
2024-03-11	RNAC	SPRINGER TIMOTHY A	1,200	0.6541	40	19.6230	785
2024-03-08	RNAC	SPRINGER TIMOTHY A	4,800	0.6639	160	19.9170	3,187
2024-02-07	RNAC	SPRINGER TIMOTHY A	2,400	0.6563	80	19.6890	1,575
2024-02-06	RNAC	SPRINGER TIMOTHY A	800	0.6500	27	19.5000	520
2024-01-17	RNAC	SPRINGER TIMOTHY A	800	0.6900	27	20.7000	552
2022-04-11	SELB	SPRINGER TIMOTHY A	6,681,600		6,681,600
2021-12-15	SELB	SPRINGER TIMOTHY A	211,190	2.9883	211,190	2.9883	631,099
2021-12-13	SELB	SPRINGER TIMOTHY A	14,592	2.9805	14,592	2.9805	43,491
2021-12-10	SELB	SPRINGER TIMOTHY A	58,681	2.9897	58,681	2.9897	175,439
2021-12-09	SELB	SPRINGER TIMOTHY A	3,748,000	3.0600	3,748,000	3.0600	11,468,880
2021-05-26	SELB	SPRINGER TIMOTHY A	926,170	4.0011	926,170	4.0011	3,705,699
2021-05-25	SELB	SPRINGER TIMOTHY A	383,830	3.5487	383,830	3.5487	1,362,098
2021-05-24	SELB	SPRINGER TIMOTHY A	590,000	3.3764	590,000	3.3764	1,992,076
2021-05-21	SELB	SPRINGER TIMOTHY A	2,773,479	3.1900	2,773,479	3.1900	8,847,398
2020-10-23	SELB	SPRINGER TIMOTHY A	994,488	2.7147	994,488	2.7147	2,699,737
2020-10-22	SELB	SPRINGER TIMOTHY A	1,770,204	2.6306	1,770,204	2.6306	4,656,699
2020-10-21	SELB	SPRINGER TIMOTHY A	880,000	2.4994	880,000	2.4994	2,199,472
2020-10-20	SELB	SPRINGER TIMOTHY A	910,000	2.2123	910,000	2.2123	2,013,193
2020-10-19	SELB	SPRINGER TIMOTHY A	759,500	2.3634	759,500	2.3634	1,795,002
2020-10-16	SELB	SPRINGER TIMOTHY A	218,196	2.4200	218,196	2.4200	528,034
2020-10-09	SELB	SPRINGER TIMOTHY A	276,703	1.9966	276,703	1.9966	552,465
2020-10-08	SELB	SPRINGER TIMOTHY A	530,441	1.8868	530,441	1.8868	1,000,836
2020-10-07	SELB	SPRINGER TIMOTHY A	654,953	1.6468	654,953	1.6468	1,078,577
2020-10-06	SELB	SPRINGER TIMOTHY A	2,000,000	1.6829	2,000,000	1.6829	3,365,800
2019-08-14	SELB	SPRINGER TIMOTHY A	10,000	1.7415	10,000	1.7415	17,415
2019-01-25	SELB	SPRINGER TIMOTHY A	4,000,000	1.5000	4,000,000	1.5000	6,000,000
2019-01-25	SELB	SPRINGER TIMOTHY A	66,666	1.5000	66,666	1.5000	99,999
2017-11-14	SELB	SPRINGER TIMOTHY A	57,598	9.2728	57,598	9.2728	534,095
2017-11-10	SELB	SPRINGER TIMOTHY A	21,586	9.0425	21,586	9.0425	195,191
2017-11-10	SELB	SPRINGER TIMOTHY A	4,752	9.0290	4,752	9.0290	42,906
2017-11-10	SELB	SPRINGER TIMOTHY A	4,752	9.0290	4,752	9.0290	42,906
2017-11-09	SELB	SPRINGER TIMOTHY A	21,100	9.3314	21,100	9.3314	196,893
2017-11-09	SELB	SPRINGER TIMOTHY A	900	9.7407	900	9.7407	8,767
2017-11-09	SELB	SPRINGER TIMOTHY A	4,900	9.3271	4,900	9.3271	45,703
2017-11-09	SELB	SPRINGER TIMOTHY A	100	9.7800	100	9.7800	978
2017-06-27	SELB	SPRINGER TIMOTHY A	338,791	17.7100	338,791	17.7100	5,999,989
2017-06-01	SELB	SPRINGER TIMOTHY A	518	13.7500	518	13.7500	7,122
2017-05-18	SELB	SPRINGER TIMOTHY A	4,860	14.0000	4,860	14.0000	68,040
2017-05-17	SELB	SPRINGER TIMOTHY A	11,244	14.0060	11,244	14.0060	157,483
2016-06-27	SELB	TAS Partners, LLC	710,000	14.0000	710,000	14.0000	9,940,000

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam RNAC / Cartesian Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam RNAC / Cartesian Therapeutics, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam SRRK / Scholar Rock Holding Corporation - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam RNAC / Cartesian Therapeutics, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2018-05-29 SRRK SPRINGER TIMOTHY A 71,428 14.0000 71,428 14.0000 999,992 197 28.77 1,054,992 105.50

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam SRRK / Scholar Rock Holding Corporation - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam RNAC / Cartesian Therapeutics, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Timothy A Springer seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2025-04-11 2025-04-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 36,338 656,513 5.86 10.77 391,455 7,072,352

2025-04-11 2025-04-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 6,412 8,643,685 0.07 10.77 69,074 93,114,961

2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 3,451 620,175 0.56 10.92 37,696 6,774,234

2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 45,144 616,724 7.90 10.43 471,055 6,435,207

2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 609 8,637,273 0.01 10.92 6,652 94,345,797

2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 7,966 8,636,664 0.09 10.43 83,121 90,119,271

2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 178 571,580 0.03 9.95 1,771 5,687,735

2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 41,604 571,402 7.85 9.43 392,176 5,386,264

2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 31 8,628,698 0.00 9.95 308 85,863,311

2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 7,342 8,628,667 0.09 9.43 69,209 81,337,267

2025-04-11 2025-04-11 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 53,706 1,503,358 3.70 16.31 875,945 24,519,769

2025-04-11 2025-04-11 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 9,478 4,334,846 0.22 16.31 154,586 70,701,338

2025-04-11 2025-04-10 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 45,858 1,449,652 3.27 16.73 767,204 24,252,678

2025-04-11 2025-04-10 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 8,092 4,325,368 0.19 16.73 135,379 72,363,407

2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 4,856 1,403,794 0.35 15.23 73,957 21,379,783

2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 16,215 1,398,938 1.17 14.62 237,063 20,452,474

2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 857 4,317,276 0.02 15.23 13,052 65,752,113

2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 2,861 4,316,419 0.07 14.62 41,828 63,106,046

2025-04-09 2025-04-07 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 412,500 1,382,723 42.52 17.10 7,053,750 23,644,563

2025-04-09 2025-04-07 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 87,500 4,313,558 2.07 17.10 1,496,250 73,761,842

2025-03-20 2025-03-20 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 54,889 8,621,325 0.64 15.59 855,593 134,386,628

2025-03-20 2025-03-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 20,234 8,566,436 0.24 14.97 302,962 128,264,390

2025-03-20 2025-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 14,740 8,546,202 0.17 14.42 212,599 123,264,435

2025-02-07 2025-02-05 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 660,000 970,223 212.75 50.00 33,000,000 48,511,150

2025-02-07 2025-02-05 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 129,294 4,226,058 3.16 54.14 6,999,977 228,798,780

2025-01-15 2025-01-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 4,022 8,531,462 0.05 18.00 72,396 153,566,316

2025-01-15 2025-01-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 8,983 8,527,440 0.11 17.78 159,738 151,636,644

2025-01-15 2025-01-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 7,962 8,518,457 0.09 16.86 134,220 143,600,741

2025-01-06 2025-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock A - Award 2,600 8,510,495 0.03

2024-12-23 2024-12-23 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 5,181 8,507,895 0.06 19.00 98,437 161,646,602

2024-12-23 2024-12-20 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 21,800 8,502,714 0.26 18.94 412,968 161,071,163

2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 3,376 8,480,914 0.04 18.93 63,901 160,526,740

2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 10,529 8,477,538 0.12 18.35 193,203 155,559,431

2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 11,303 8,467,009 0.13 17.39 196,512 147,205,725

2024-11-18 2024-11-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 20,181 8,455,706 0.24 18.42 371,736 155,754,950

2024-11-18 2024-11-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 38,114 8,435,525 0.45 17.96 684,447 151,484,314

2024-11-18 2024-11-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 277,246 8,397,411 3.41 17.09 4,739,188 143,543,664

2024-11-18 2024-11-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 22,242 8,120,165 0.27 16.97 377,436 137,795,140

2024-11-18 2024-11-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 74,157 8,097,923 0.92 16.19 1,200,720 131,118,330

2024-10-24 2024-10-22 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 300,000 4,096,764 7.90 33.59 10,077,000 137,610,303

2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 4,879 8,023,766 0.06 23.93 116,769 192,032,792

2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 16,650 8,018,887 0.21 23.57 392,372 188,972,289

2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 48,880 8,002,237 0.61 22.35 1,092,673 178,883,606

2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 9,892 7,953,357 0.12 21.35 211,195 169,804,967

2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 8,043 7,943,465 0.10 21.86 175,840 173,664,004

2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 21,278 7,935,422 0.27 21.17 450,560 168,031,767

2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 50,489 7,914,144 0.64 20.18 1,018,878 159,709,009

2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 10,249 7,863,655 0.13 19.01 194,859 149,507,741

2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 29,847 7,853,406 0.38 18.25 544,576 143,290,105

2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock J - Other 317,879 330,695 2,480.33

2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock J - Other -2,119,193 529,798 -80.00

2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 5,514 7,823,559 0.07 17.38 95,822 135,957,026

2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock J - Other 1,801,314 7,818,045 29.94

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 1,307 12,816 11.36

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock M - Exercise -1,307 0 -100.00

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 721,361 2,648,991 37.42

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock M - Exercise -721,361 0 -100.00

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 1,636,832 6,016,731 37.37

2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock M - Exercise -1,636,832 0 -100.00

2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 2,400 3,796,764 0.06 30.87 74,088 117,206,105

2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 4,070 3,794,364 0.11 30.10 122,507 114,210,356

2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 18,999 3,790,294 0.50 29.13 553,441 110,411,264

2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock P - Purchase 24,531 3,771,295 0.65 28.16 690,793 106,199,667

2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock J - Other 186,134 186,134

2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock J - Other 1,054,759 3,746,764 39.18

2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock J - Other -1,240,893 310,223 -80.00

2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock U - Other -42,873 0 -100.00

2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock U - Other -2,768,893 0 -100.00

2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock U - Other -4,608,052 0 -100.00

2024-08-14 2024-08-12 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 8,016 11,509 229.49 12.72 101,968 146,400

2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock A - Award 1,307 1,307 20.00 26,140 26,140

2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock A - Award 721,361 721,361 20.00 14,427,220 14,427,220

2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock A - Award 1,636,832 1,636,832 20.00 32,736,640 32,736,640

2024-06-24 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock A - Award 1,551,116 1,551,116

2024-06-24 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock A - Award 2,692,005 2,692,005

2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 826,169 1,927,630 75.01

2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Series A Non-Voting Convertible Preferred Stock M - Exercise -24,785 0 -100.00

2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 4,130,846 4,379,899 1,658.62

2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Series A Non-Voting Convertible Preferred Stock M - Exercise -123,925 0 -100.00

2024-03-28 2024-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 800 104,818 0.77 0.61 488 63,939

2024-03-28 2024-03-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 1,200 104,018 1.17 0.56 672 58,250

2024-03-28 2024-03-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 2,000 102,818 1.98 0.53 1,061 54,545

2024-03-28 2024-03-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 3,200 100,818 3.28 0.58 1,868 58,847

2024-03-28 2024-03-12 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 1,200 97,618 1.24 0.61 735 59,762

2024-03-28 2024-03-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 1,200 96,418 1.26 0.65 785 63,067

2024-03-28 2024-03-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 4,800 95,218 5.31 0.66 3,187 63,215

2024-03-28 2024-02-07 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 2,400 90,418 2.73 0.66 1,575 59,341

2024-03-28 2024-02-06 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 800 88,018 0.92 0.65 520 57,212

2024-03-28 2024-01-17 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 800 87,218 0.93 0.69 552 60,180

2024-03-26 2024-03-26 4 RNAC Cartesian Therapeutics, Inc.
Common Stock M - Exercise 1,970,443 33,043,849 6.34 1.46 2,876,847 48,244,020

2024-03-20 2024-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 19,044 31,073,406 0.06 0.60 11,398 18,597,433

2024-03-18 2024-03-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 537,500 31,054,362 1.76 0.59 314,545 18,173,013

2024-03-18 2024-03-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock P - Purchase 648,372 30,516,862 2.17 0.54 351,677 16,552,346

2024-01-04 2024-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock A - Award 178,000 7,471,625 2.44

2023-11-15 2023-11-15 4 RNAC Cartesian Therapeutics, Inc.
Series A Convertible Preferred Stock A - Award 123,925 123,925 403.47 49,999,998 49,999,998

2023-11-15 2023-11-15 4 RNAC Cartesian Therapeutics, Inc.
Series A Convertible Preferred Stock A - Award 24,785 24,785 403.47 9,999,999 9,999,999

2023-06-30 2023-06-28 4 MORF Morphic Holding, Inc.
Common Stock J - Other 429 2,768,893 0.02

2023-06-30 2023-06-28 4 MORF Morphic Holding, Inc.
Common Stock J - Other 429 2,768,893 0.02

2023-05-04 2023-05-03 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 1,050,000 2,768,464 61.10 45.00 47,250,000 124,580,880

2023-02-13 2023-02-13 4 MORF Morphic Holding, Inc.
Common Stock A - Award 806,223 1,718,464 88.38 35.35 28,499,983 60,747,702

2023-02-13 2023-02-13 4 MORF Morphic Holding, Inc.
Common Stock A - Award 42,432 4,607,623 0.93 35.35 1,499,971 162,879,473

2022-04-29 2021-06-16 4/A MORF Morphic Holding, Inc.
Director Stock Option (right to buy) A - Award 9,996 9,996

2022-04-13 2022-04-11 4 SELB SELECTA BIOSCIENCES INC
Warrant (right to buy) A - Award 5,011,200 5,011,200

2022-04-13 2022-04-11 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 6,681,600 29,868,490 28.82

2022-01-05 2022-01-03 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 40,000 40,000

2021-12-17 2021-12-15 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 211,190 23,186,890 0.92 2.99 631,099 69,289,383

2021-12-13 2021-12-13 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 14,592 22,975,700 0.06 2.98 43,491 68,479,074

2021-12-13 2021-12-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 58,681 22,961,108 0.26 2.99 175,439 68,646,825

2021-12-13 2021-12-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 3,748,000 22,902,427 19.57 3.06 11,468,880 70,081,427

2021-08-20 2021-08-20 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 11,511 912,241 1.28 56.80 653,839 51,816,383

2021-08-20 2021-08-20 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 109 900,730 0.01 56.01 6,105 50,448,896

2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 13,874 900,621 1.56 56.82 788,339 51,174,456

2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 18,916 886,747 2.18 56.31 1,065,183 49,933,788

2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 210 867,831 0.02 54.71 11,488 47,475,302

2021-08-20 2021-08-18 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 9,208 867,621 1.07 56.35 518,845 48,888,014

2021-08-20 2021-08-18 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 21,099 858,413 2.52 55.42 1,169,357 47,575,309

2021-06-17 2021-06-16 4 MORF Morphic Holding, Inc.
Director Stock Option (right to buy) A - Award 12,000 12,000

2021-05-26 2021-05-26 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 926,170 19,154,427 5.08 4.00 3,705,699 76,638,778

2021-05-26 2021-05-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 383,830 18,228,257 2.15 3.55 1,362,098 64,686,616

2021-05-26 2021-05-24 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 590,000 17,844,427 3.42 3.38 1,992,076 60,249,923

2021-05-26 2021-05-26 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 2,413 837,314 0.29 47.36 114,285 39,657,117

2021-05-26 2021-05-26 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 22,587 834,901 2.78 46.93 1,060,015 39,182,154

2021-05-26 2021-05-25 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 8,441 812,314 1.05 46.11 389,225 37,456,855

2021-05-26 2021-05-25 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 56,559 803,873 7.57 45.83 2,592,156 36,842,303

2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 7,550 747,314 1.02 47.10 355,586 35,196,621

2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 27,426 739,764 3.85 46.54 1,276,491 34,430,910

2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 5,024 712,338 0.71 45.43 228,234 32,360,661

2021-05-25 2021-05-21 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 2,773,479 17,254,427 19.15 3.19 8,847,398 55,041,622

2021-05-25 2021-05-21 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 232,295 707,314 48.90 45.50 10,569,422 32,182,787

2021-04-01 2021-03-30 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 40,000 40,000

2021-03-08 2021-03-05 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 100,000 475,019 26.67 70.00 7,000,000 33,251,330

2020-10-23 2020-10-23 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 994,488 14,480,948 7.37 2.71 2,699,737 39,311,430

2020-10-23 2020-10-22 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 1,770,204 13,486,460 15.11 2.63 4,656,699 35,477,482

2020-10-23 2020-10-21 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 880,000 11,716,256 8.12 2.50 2,199,472 29,283,610

2020-10-20 2020-10-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 910,000 10,836,256 9.17 2.21 2,013,193 23,973,049

2020-10-20 2020-10-19 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 759,500 9,926,256 8.29 2.36 1,795,002 23,459,713

2020-10-20 2020-10-16 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 218,196 9,166,756 2.44 2.42 528,034 22,183,550

2020-10-14 2020-10-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 276,703 8,948,560 3.19 2.00 552,465 17,866,695

2020-10-08 2020-10-08 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 530,441 8,671,857 6.52 1.89 1,000,836 16,362,060

2020-10-08 2020-10-07 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 654,953 8,141,416 8.75 1.65 1,078,577 13,407,284

2020-10-08 2020-10-06 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 2,000,000 7,486,463 36.45 1.68 3,365,800 12,598,969

2020-06-23 2020-06-19 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 20,000 20,000

2020-06-19 2020-06-18 4 MORF Morphic Holding, Inc.
Director Stock Option (right to buy) A - Award 12,000 12,000

2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Warrants A - Award 1,970,443 1,970,443 0.12 246,305 246,305

2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Common Stock A - Award 3,940,887 5,486,463 254.98 1.46 5,753,695 8,010,236

2019-12-16 2019-12-12 4 SELB SELECTA BIOSCIENCES INC
Common Stock J - Other 1,237,028 7,293,625 20.42

2019-12-12 2019-12-10 4 SRRK Scholar Rock Holding Corp
Common Stock G - Gift -296,000 2,376,567 -11.08

2019-12-09 2019-12-05 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock) A - Award 90,000 90,000

2019-09-05 2019-09-03 4 SELB Scholar Rock Holding Corp
Common Stock J - Other -1,237,028 0 -100.00

2019-09-05 2019-09-03 4 SELB SELECTA BIOSCIENCES INC
Common Stock J - Other -1,237,028 0 -100.00

2019-08-21 2019-08-19 4 SRRK Scholar Rock Holding Corp
Common Stock G - Gift -296,000 2,672,567 -9.97

2019-08-20 2019-08-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock A - Award 1,100,000 1,545,576 246.87 1.81 1,991,000 2,797,493

2019-08-20 2019-08-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock A - Award 1,600,000 6,056,597 35.90 1.81 2,896,000 10,962,441

2019-08-16 2019-08-14 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 10,000 86,418 13.09 1.74 17,415 150,497

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series Seed Preferred Stock C - Conversion -341,686 0 -100.00

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series B Preferred Stock C - Conversion -1,345,569 0 -100.00

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series A Preferred Stock C - Conversion -2,286,588 0 -100.00

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series Seed Preferred Stock C - Conversion -332,805 0 -100.00

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock P - Purchase 33,333 375,019 9.76 15.00 499,995 5,625,285

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock C - Conversion 341,686 341,686

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock C - Conversion 1,345,569 4,565,191 41.79

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock C - Conversion 2,286,588 3,219,622 245.07

2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock C - Conversion 332,805 933,034 55.45

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,457,698

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 900,342

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,071,836

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,457,698

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 900,342

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,071,836

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,457,698

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 900,342

2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 1,071,836

2019-06-18 2019-06-14 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 10,000 10,000

2019-03-29 2019-01-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 66,666 76,418 683.61 1.50 99,999 114,627

2019-03-29 2019-01-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 4,000,000 4,456,597 876.05 1.50 6,000,000 6,684,896

2019-03-29 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 4,752 9,752 95.04 9.03 42,906 88,051

2018-06-26 2018-06-22 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy) A - Award 20,316 20,316

2018-06-19 2018-06-15 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 10,000 10,000

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-4 Preferred C - Conversion -787,649 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series C Preferred C - Conversion -855,391 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series B Preferred C - Conversion -2,094,875 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-3 Preferred C - Conversion -1,449,275 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-2 Preferred C - Conversion -1,491,792 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-1 Preferred C - Conversion -1,000,000 0 -100.00

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 275,903 275,903

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock P - Purchase 71,428 3,273,519 2.23 14.00 999,992 45,829,266

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 299,632 3,202,091 10.32

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 733,808 2,902,459 33.84

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 507,662 2,168,651 30.56

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 522,556 1,660,989 45.90

2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock C - Conversion 350,287 1,138,433 44.44

2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock 1,576,292

2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock 1,576,292

2017-11-16 2017-11-14 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 57,598 461,349 14.27 9.27 534,095 4,277,997

2017-11-13 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 4,752 403,751 1.19 9.03 42,906 3,645,468

2017-11-13 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 21,586 398,999 5.72 9.04 195,191 3,607,948

2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 100 5,000 2.04 9.78 978 48,900

2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 4,900 4,900 9.33 45,703 45,703

2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 900 377,413 0.24 9.74 8,767 3,676,267

2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 21,100 376,513 5.94 9.33 196,893 3,513,393

2017-06-28 2017-06-27 4 SELB SELECTA BIOSCIENCES INC
Warrant (right to buy) P - Purchase 79,130 79,130 0.12 9,891 9,891

2017-06-28 2017-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 338,791 355,413 2,038.21 17.71 5,999,989 6,294,364

2017-06-20 2017-06-16 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) A - Award 6,410 6,410

2017-06-02 2017-06-01 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 518 16,622 3.22 13.75 7,122 228,552

2017-05-19 2017-05-18 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 4,860 16,104 43.22 14.00 68,040 225,456

2017-05-19 2017-05-17 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 11,244 11,244 14.01 157,483 157,483

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock C - Conversion -79,156 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock C - Conversion -84,421 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock C - Conversion -51,355 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock C - Conversion -63,547 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock C - Conversion -93,954 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock C - Conversion -153,742 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series B Convertible Preferred Stock C - Conversion -157,864 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series B Convertible Preferred Stock C - Conversion -157,864 0 -100.00

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock P - Purchase 710,000 1,237,028 134.72 14.00 9,940,000 17,318,392

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock C - Conversion 425,874 445,576 2,161.58

2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock C - Conversion 506,015 527,028 2,408.10

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 61,728

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 60,417

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 61,728

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 60,417

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 61,728

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 60,417

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 61,728

2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 60,417

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)